Skip to main content
. 2022 Jul 1;13:725679. doi: 10.3389/fimmu.2022.725679

Figure 2.

Figure 2

Association between survival and CCND1 amplification in patients with melanoma. Kaplan-Meier survival analysis of melanoma patients, regardless of ICI use, calculated using data from (A) the MSKCC database (n=306) and (B) the TCGA database (n=246). ICI, immune checkpoint inhibitor; MSKCC, the Memorial Sloan Kettering Cancer Center; TCGA, The Cancer Genome Atlas.